COMBINATIONS AND COMPOSITIONS EFFECTING ON FUNCTION OF VEGF/VEGF RECEPTOR AND ANGIOPOIETIN/TIE(II) RECEPTOR SYSTEMS AND USES THEREOF Russian patent published in 2007 - IPC A61K45/06

Abstract RU 2292221 C2

FIELD: biochemistry.

SUBSTANCE: invention relates to designing of compositions effecting on biological activity of systems comprising vascular endothelium growth factor (VEGF), compound I, effecting on biological function of systems comprising angiopoietin/TIE receptor, compound II.

EFFECT: improved method for effective vascularization and cancer treatment.

23 cl, 6 tbl, 6 dwg

Similar patents RU2292221C2

Title	Year	Author	Number
BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES	2014	Bener Monika Brinkmann Ulrikh Zhorzh Gi Griep Remko-Albert Imkhof-Yung Zabine Kavle Anita Kettenberger Khubert Klajn Kristian Regula Jerg Tomas Shefer Volfgang Shantser Yurgen Mikhael Shojer Verner Zeeber Shtefan Tomas Markus	RU2640253C2
BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES	2009	Monika Behner Ul'Rikh Brinkmann Gi Zhorzh Remko-Al'Bert Griep Zabine Imkhof-Jung Anita Kavl'E Khubert Kettenberger Kristian Klajn Jerg Tomas Regula Vol'Fgang Shehfer Jurgen Mikhaehl' Shantser Verner Shojer Shtefan Zeeber Markus Tomas	RU2542382C2
BISPECIFIC BIVALENT ANTI-VEGF/ANTI-ANG-2 ANTIBODIES	2011	Bener Monika Imkhof-Yung Zabine Kavle Anita Kettenberger Gubert Klyajn Kristian Regula Jorg Tomas Shefer Volfgang Shantser Jyurgen Mikhel Shojer Verner Shtubenraukh Kaj-Gunnar Tomas Markus	RU2597973C2
DOUBLE-TARGETED ANTIBODY IN NEW FORM AND USING IT	2009	Eo Dzhin San Li Von Sup Kim Sun Vu Shim San Rel	RU2520824C2
ANTIBODIES AGAINST HUMAN ANGIOPOIETIN-2	2009	Brinkmann Ul'Rikh Grip Remko-Albert Kalutsa Klaus Kavl'E Anita Klajn Kristian Regula Jerg Tomas Shojer Verner	RU2569461C2
ANTIBODIES AGAINST HUMAN ANGIOPOIETIN-2	2009	Ul'Rikh Brinkmann Remko-Albert Grip Klaus Kalutsa Anita Kavl'E Kristian Klajn Jerg Tomas Regula Verner Shojer	RU2569107C2
ISOLATED TIE-LIGAND-4 AND ITS ISOLATED FIBRINOGEN-LIKE DOMAIN; ISOLATED NUCLEIC ACID MOLECULE ENCODING INDICATED LIGAND; VECTOR COMPRISING INDICATED NUCLEIC ACID; METHOD FOR PREPARING HOST-CELL TRANSFORMED WITH INDICATED VECTOR; METHOD FOR PREPARING TIE-LIGAND-4; CONJUGATE COMPRISING INDICATED LIGAND; LIGAND-BODY COMPRISING INDICATED FIBRINOGEN-LIKE DOMAIN	1997	Valenzuela Dehvid M. Dzhounz Pamela F. Jankopoulos Dzhordzh D.	RU2242514C2
HUMANIZED ANTI-VEGF MONOCLONAL ANTIBODY	2020	Shie Lianzy San Chanyun Vang Rui Chzhan Ksyao	RU2809746C2
ANGIOGENESIS PROMOTING AGENT AND METHODS FOR ITS USE	2018	Dyumon Daniel Van Slajk Pol Tamelti Devid Sokoll Kennet Moss Dzhejson	RU2771982C2
OPTIMIZED OPTIONS OF ANTI-VEGF ANTIBODIES	2016	Koenig Patrick Lee Chingwei Vivian Rajagopal Karthikan Famili Amin Fuh Germaine	RU2763916C2

RU 2 292 221 C2

Authors

Zimajster Gerkhard

Khaberehj Martin

Tiraukh Karl-Khajnts

Dates

2007-01-27—Published

2001-06-20—Filed